Transversus Abdominis Plane Block During Kidney Transplant Surgery

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02080728
• Date of registration: 05/03/2014
• Prospective Registration: No
• Primary sponsor: Centre Hospitalier Universitaire Dijon
• Public title: Transversus Abdominis Plane Block During Kidney Transplant Surgery
• Scientific title: Transversus Abdominis Plane Block During Kidney Transplant Surgery: Prospective Controlled Randomized Double-blind Trial Comparing Ropivacaine 0.2% With Placebo.
• Date of first enrolment: July 23, 2013
• Target sample size: 50
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02080728
• Study type: Interventional
• Study design: Allocation: Randomized. Intervention model: Parallel Assignment. Masking: Double.
• Phase: Phase 4

Countries of recruitment

France

Key inclusion & exclusion criteria

Inclusion Criteria:

- Patient opéré for kidney transplant

- Patients who have provided written informed consent

- Patients with national health insurance cover

- Patients aged 18 years and above

Exclusion Criteria:

- Pregnant or breast-feeding women

- allergies/hypersensitivity to paracetamol (or propacetamol chlorhydrate (paracetamol
pro-drug) or one of its excipients), to local anesthetics, morphines (or other
constituents)

- patients under guardianship or ward of court



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Kidney Transplant

Intervention(s)

Drug: Ropivacaine 500mg/100ml Naropeine

Drug: 0.9% sodium chloride BAXTER

Primary Outcome(s)

Mesurement of VAS (Visual analogue scale) scores for pain [Time Frame: During the first 24 hours post-op]

Secondary Outcome(s)

Measurement of analgesic consomption [Time Frame: During the first 24 hours post-op]

Secondary ID(s)

Jazayeri-Steinmetz AOI 2012

Source(s) of Monetary Support

Please refer to primary and secondary sponsors